Market
How will markets react to PureHealth's acquisition by March 31, 2025?
2
Resolution / Starting Odds
Stock prices increase • 25%
Stock prices decrease • 25%
Stock prices remain stable • 25%
No significant change • 25%
Stock market data, financial analysis reports
Story
PureHealth Acquires 60% Stake in Hellenic Healthcare Group from CVC Capital for $2.3 Billion
Jan 27, 2025, 02:38 PM
Abu Dhabi-based PureHealth is acquiring a 60% stake in Hellenic Healthcare Group from CVC Capital Partners, marking a significant move in the healthcare sector. The deal is valued at approximately $2.3 billion, reflecting the growing interest of foreign investment in Greece's healthcare landscape. CVC Capital, which has been a dominant player in Greece's private hospital sector, is reportedly selling the majority stake as part of its strategy to capitalize on the increased valuation of its investments. This acquisition aligns with PureHealth's expansion strategy in the healthcare market.
View original story
Similar markets
Positive • 25%
Neutral • 25%
Unchanged • 25%
Negative • 25%
Positive with increased trading volume • 25%
Negative with decreased trading volume • 25%
Mixed reactions • 25%
Neutral with stable trading volume • 25%
No change • 25%
Increase by 0-10% • 25%
Increase by more than 10% • 25%
Decrease • 25%
J&J stock falls by more than 5% • 25%
J&J stock rises by more than 5% • 25%
J&J stock remains within 5% of current price • 25%
Other • 25%
No significant increase • 25%
Increase by more than 10% • 25%
Increase by 5-10% • 25%
Increase by less than 5% • 25%
Microsoft • 25%
Nvidia • 25%
Apple • 25%
Amazon • 25%
Significant increase (>10%) • 25%
Moderate increase (0-10%) • 25%
No change or decrease • 25%
Significant decrease (>10%) • 25%
Over $12 billion • 25%
$10 billion to $12 billion • 25%
$8 billion to $10 billion • 25%
Under $8 billion • 25%
No • 50%
Yes • 50%
Eli Lilly • 25%
Pfizer • 25%
Other • 25%
GSK • 25%